The California Department of Cannabis Control (DCC) has simplified the process for cannabis businesses to switch their license designation from recreational to medical, a change designed to help them access federal tax benefits following the Trump administration's decision to move medical marijuana from Schedule I to Schedule III of the Controlled Substances Act.
The U.S. Department of Justice announced last week that state-licensed medical cannabis products immediately transferred to Schedule III, as did any FDA-approved cannabis products. A broader administrative hearing covering recreational cannabis rescheduling is set for this summer.
The shift to Schedule III removes these products from federal tax code section 280E, which bars cannabis companies from claiming standard business deductions available to other industries. Adult-use marijuana remains on Schedule I and stays subject to 280E for now.
On Thursday, DCC announced that cultivation licensees can now request a designation change at any time rather than waiting for license renewal. The department also dropped its requirement for new local authorization when a business wants to switch to a medical-only designation or add a medical designation alongside an existing adult-use one.
"These changes are intended to simplify the request process and expedite the review process," DCC said, adding that businesses must continue operating under their current designation until DCC approves the change.
The department cautioned that the announcement "should not be considered advice regarding whether or how licensees should participate in the federal medicinal cannabis program," directing businesses to consult legal counsel. DCC also disclosed that it sought a meeting with Drug Enforcement Administration (DEA) officials overseeing rescheduling implementation, but the DEA "has indicated it will share information publicly and all at once, rather than through state-specific briefings."
"DCC will continue to monitor federal updates as they are released, and we remain committed to supporting regulatory alignment and simplifying processes wherever possible," the department said.
To claim 280E relief, state-licensed medical cannabis businesses must submit an operational information form through the DEA's website. The U.S. Department of the Treasury and the Internal Revenue Service have also announced plans to issue updated tax guidance for the cannabis industry following rescheduling.
